Biogen | 8-K: Biogen reports strong second quarter 2024 results and raises full year 2024 financial guidance; Second quarter 2024 total revenue of $2.5 billion, GAAP diluted EPS of $4.00 and Non-GAAP diluted EPS of $5.28
Biogen | 8-K: Biogen reports strong second quarter 2024 results and raises full year 2024 financial guidance; Second quarter 2024 total revenue of $2.5 billion, GAAP diluted EPS of $4.00 and Non-GAAP diluted EPS of $5.28
渤健公司 | 8-K：Biogen公布了强劲的2024年第二季度业绩，并上调了2024年全年财务指导；2024年第二季度总收入为25亿美元，GAAP摊薄后每股收益为4.00美元，非公认会计准则摊薄每股收益为5.28美元